Joey A. Jacobs, Chairman & Chief Executive Officer Acadia Healthcare Inc, joined Acadia in February 2011 and has served as the Chairman of the Acadia board of directors and as Acadia’s Chief Executive Officer since that time. Mr. Jacobs has extensive experience in the behavioral health industry. Prior to joining the Company in 2011, he co-founded Psychiatric Solutions, Inc. ("PSI") and served as Chairman, President and Chief Executive Officer of PSI from April 1997 to November 2010. Prior to founding PSI, Mr. Jacobs served for 21 years in various capacities with Hospital Corporation of America ("HCA," also formerly known as Columbia and Columbia/HCA). Mr. Jacobs serves on the board of directors of Envision (formerly AmSurg Corporation), Cumberland Pharmaceuticals, Inc., Mental Health Management, Inc., The Nashville Healthcare Council, The Jason Foundation and Monroe Carell Jr. Children’s Hospital at Vanderbilt. Mr. Jacobs was recently nominated by Governor Bill Haslam and confirmed by the Tennessee General Assembly to serve on the Middle Tennessee State University Board of Trustees.
E. Perot Bissell, Director, has served as a director of Acadia since April 2013. Since 2012, Mr. Bissell has been the Vice Chairman of Maxum Enterprises, LLC. From 2006 to 2012, he served as Chief Executive Officer for Maxum Petroleum, Inc., an independent energy logistics company. Prior to that, Mr. Bissell was a Partner of Northwest Capital Appreciation, Inc., a merchant banking and private equity firm, and before that, the Co-Managing Partner and Chief Financial Officer of SLP Capital, a specialty finance company. Our Board believes that Mr. Bissell is qualified to serve as a director because of, among other things, his extensive corporate finance background and his general business and financial acumen. Mr. Bissell currently serves on the board of directors of Maxum Enterprises, LLC and previously served on the board of ASG Security, LLC, Maxum Petroleum, Inc., SLP Capital and SPI Petroleum, LLC, all private companies. Mr. Bissell also serves on a number of charitable boards.
Christopher R. Gordon, Director, has served as a director of Acadia since February 2015. Mr. Gordon has been a Managing Director of Bain Capital Partners, LLC (“BCP”) since 2009. Prior to joining BCP, Mr. Gordon was a consultant at Bain & Company, Inc. Mr. Gordon currently serves as a director of Air Medical Group Holdings, Inc., Beacon Health Options, Physio Control, Inc., Quintiles Transnational Corporation and Grupo Notre Dame Intermedica. Mr. Gordon also serves on the board of directors for Year Up – Boston, the Boston Medical Center Foundation Board, the Boston Medical Center Health Plan Board and serves as a Trustee of the Dana Farber Cancer Center. Our Board believes that Mr. Gordon is qualified to serve as a director due to, among other things, his experience in the healthcare industry and his general business and financial acumen. Mr. Gordon was designated as a director by Bain Capital.
Vicky Gregg, Director, has served as a director of Acadia since May 2016. Since November 2014, Ms. Gregg has served as a Co-Founder and Partner of Guidon Partners, an investor and consultant for an array of privately held healthcare companies. She was previously with BlueCross BlueShield of Tennessee (BCBST), which she joined in 1995 and which she served as Chief Executive Officer from January 2003 through the end of 2012. During this period, she was appointed by Senate Majority Leader Bill Frist to the National Institutes of Health Commission on Systemic Interoperability; served on the Board of America’s Health Insurance Plans, including two years as Chairman; served on the Board of the BlueCross BlueShield Association; was Chairman of the Board of the National Institute of Healthcare Management; and was appointed by Governor Bill Haslam to the University of Tennessee Board of Trustees. Prior, to BCBST, Ms. Gregg was with Humana Health Plans, most recently as CEO for Kentucky, Ohio and Southern Indiana, as well as Director of Marketing for Retirement Centers of America. She began her career as a nurse technician at Erlanger Regional Medical Center and became a Staff Nurse in Emergency Medicine, as well as a Clinical Nurse Specialist in Erlanger’s End Stage Renal Disease Program. Ms. Gregg also serves on the Board of Directors of two other public companies, Quest Diagnostics and Team Health.
William F. Grieco, Director, has served as a director of Acadia since November 2011 and as a director of PHC since February 1997. Since 2008, Mr. Grieco has served as the Managing Director of Arcadia Strategies, LLC, a legal and business consulting organization servicing healthcare, science and technology companies. From 2003 to 2008, he served as Senior Vice President and General Counsel of American Science and Engineering, Inc., an x-ray inspection technology company. From 2001 to 2002, he served as Senior Vice President and General Counsel of IDX Systems Corporation, a healthcare information technology company. Previously, from 1995 to 1999, he was Senior Vice President and General Counsel for Fresenius Medical Care North America, a dialysis service and products company. Prior to that, Mr. Grieco was a partner at Choate, Hall & Stewart, a general service law firm. Since February 2011, Mr. Grieco has been a member of the board of directors of Echo Therapeutics Inc., a medical device and specialty pharmaceutical company. From February 1997 until November 2011, Mr. Grieco served as a member of the board of directors of PHC, Inc.
Wade D. Miquelon, Director, has served as a director of Acadia since January 2012. Mr. Miquelon is the former Executive Vice President and Chief Financial Officer of Walgreen Co (“Walgreens”), a position in which he served until August 2014. Mr. Miquelon joined Walgreens in June 2008 as Senior Vice President and Chief Financial Officer. Prior to Walgreens, he was Executive Vice President and Chief Financial Officer at Tyson Foods, Inc. from 2006 to 2008. From 1989 to 2006, Mr. Miquelon served Procter & Gamble Co. (“P&G”) in a number of positions of increasing responsibility, most recently for three years as Vice President—Finance, Western Europe, the senior most financial officer responsible for the 17-country Western Europe operation. Among other positions during his tenure at P&G, Mr. Miquelon was the head of Finance and Accounting for the ASEAN, Australasia, and India region, served as Director and Investment Partner of I Ventures, a P&G venture capital fund, and co-founded and served as Chief Financial Officer and Senior Vice President of Business Development/Human Resources of Emmperative, Inc., an enterprise marketing management software joint venture between P&G and other entities.
William M. Petrie, M.D., Director, has served as a director of Acadia since October 2012. He is currently Professor of Clinical Psychiatry in the Department of Psychiatry at the Vanderbilt University School of Medicine, where he has served for more than 20 years. He is also Director, Vanderbilt Senior Assessment Clinic in the Department of Psychiatry at the Vanderbilt University School of Medicine. Previously, Dr. Petrie served as President and Co-Director of Research at Psychiatric Consultants, P.C., a leading psychiatry practice in Nashville, TN and Chairman, Department of Psychiatry, Parthenon Pavilion at Centennial Medical Center. With 35 years experience in conducting clinical research trials, Dr. Petrie was the primary investigator for a substantial variety of clinical studies. In addition, Dr. Petrie is a noted researcher, who has published dozens of papers in numerous healthcare publications. Dr. Petrie served as a director for Psychiatric Solutions, Inc. from September 2004 until November 2010.
Hartley R. Rogers, Director, has served as a director of Acadia since April 2013. Mr. Rogers is the Chairman of Hamilton Lane Advisors, a global private equity investment firm. Prior to joining Hamilton Lane in 2004, Mr. Rogers was a Managing Director in the Private Equity Division at Credit Suisse First Boston. In that capacity, he served as a senior partner and member of the Investment Committee of DLJ Merchant Banking Partners III, a private equity fund, and as a co-head of CSFB Equity Partners, a private equity fund. Prior to joining Credit Suisse in 1997, Mr. Rogers was a Managing Director at Morgan Stanley & Co., where he was the President of the General Partners of the Princes Gate Investors family of private equity funds and Head of the Morgan Stanley Bridge Fund. A graduate of Harvard College and Harvard Business School, Mr. Rogers worked at Morgan Stanley at various times and in various capacities from 1981 to 1997. Our Board believes that Mr. Rogers is qualified to serve as a director because of, among other things, his extensive finance background and his general business and financial acumen. Mr. Rogers has served on the board of directors of various private companies including Hamilton Lane Advisors and currently serves on the board of the Metropolitan Opera.
Bruce A. Shear, Executive Vice Chairman, joined Acadia in November 2011 and serves as a director of our Board and as our Executive Vice Chairman. Prior to joining the Company, Mr. Shear served as President, Chief Executive Officer and a director of PHC since 1980 and Treasurer of PHC from September 1993 until February 1996. From 1976 to 1980, he served as Vice President, Financial Affairs, of PHC. Mr. Shear has served on the Board of Governors of the Federation of American Health Systems for over fifteen years and is currently a member of the Board of Directors of the National Association of Psychiatric Health Systems. Since November 2003, Mr. Shear has been a member of the Board of Directors of Vaso Active Pharmaceuticals, Inc., a company marketing and selling over-the-counter pharmaceutical products that incorporate Vaso’s transdermal drug delivery technology.
Reeve B. Waud, Lead Director, has served as a director of Acadia (and was Chairman of its predecessor Acadia Healthcare Company, LLC) since December 2005. Mr. Waud formed WCP in 1993 and has served as the Managing Partner of WCP since that time. Prior to founding WCP, Mr. Waud was an investment professional at Golder, Thoma, Cressey, Rauner, Inc. (“GTCR”), a private equity investment group based in Chicago, Illinois. Before joining GTCR, Mr. Waud was in the Corporate Finance Group of Salomon Brothers Inc and was a founding member of its Venture Capital Group. Mr. Waud is a Trustee, Chairman of the Audit and Risk Committee and a member of the Executive Committee of St. Paul’s School in Concord, New Hampshire and is a member of the Executive Committee and Chairman of the Finance and Audit Committee of the John G. Shedd Aquarium. He is a member of the Northwestern Memorial HealthCare (NMHC) Finance Committee which oversees the finances of NMHC and its 7 hospitals, more than 24,000 employees and approximately $9.5 billion of assets. He is a Trustee of the Art Institute of Chicago and serves on its Finance Committee and serves as the Vice Chairman and a member of the Executive Committee of The Economic Club of Chicago. In addition, Mr. Waud is the Chairman of the Illinois State Police Merit Board which has oversight responsibility for the State Police. He was appointed by the Governor of Illinois and confirmed by the Senate.
|Print Page | RSS Feeds | E-mail Alerts | Tear Sheet|